Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 21, 2024 4:25pm
RE:RE:Stay tuned
Like SPCEO said there must be a pickle with Egrifta manaufacturing since we were told that early november would see the PSA filed and the 4 months revision timeline started. Nothing yet so it
...more
(40)
•••
Lee430
X
View Profile
View Bullboard History
Comment by
Lee430
on Nov 21, 2024 11:53am
RE:Stay tuned
I must say it feels like we are on the precipice of either total collapse from Engrifa SV & F8 debacles or something spectacular with TH1902 results & partnerships….Unfortunately with Thera’s
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 21, 2024 11:04am
RE:RE:Even better Nash news from Novo Nordisk
The only espectations I have is for the spending on Th1902 will stop and the whole program will be benched like the Nash progrma for lack of interest from a partner unless truly amazing results come
...more
(54)
•••
PWIB123
X
View Profile
View Bullboard History
Comment by
PWIB123
on Nov 21, 2024 10:46am
RE:Even better Nash news from Novo Nordisk
I see this as primarily a negative for THTX. They've wasted the possibility of playing in the NASH/MASH space as others race forward with potential drugs that could hit the market. At
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Nov 21, 2024 6:55am
Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed
A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
read article.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Nov 19, 2024 8:35pm
Stay tuned
So what in store between now and the end of the year... Egrifta shortage (unreal), F8 (ok, can't manufacture F4 atm), TH1902 (no news is good news.. at least not bad news yet). I'm sure
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 19, 2024 8:15pm
RE:Even better Nash news from Novo Nordisk
At least that's burried overthere. Can't imagine the waste of money that would have been.
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Post by
palinc2000
on Nov 19, 2024 8:02pm
Even better Nash news from Novo Nordisk
https://seekingalpha.com/news/4309561-novo-nordisksemaglutidephase-3-trialfor-mas-hmeetsprimaryendpoints
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Post by
palinc2000
on Nov 19, 2024 7:59pm
Nash news from Viking
https://seekingalpha.com/news/4309209-viking-phase-2b-study-of-nash-candidate-hits-primary-endpoint
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Nov 19, 2024 12:18pm
Th1902 Results
What would define results deemed good enough to secure a decent partnership. I heard of at least 30% patient response and 30% improvement over existing therapies. Something like that.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 16, 2024 9:36pm
RE:RE:SPCEO, are you still around ?
Well, if there is an issue with Egrifta we should know about it. I've been asking since Oct. 21 if the batch was produced. They know and it's material. When and if we ear that they
...more
(43)
•••
SPCEO1
X
View Profile
View Bullboard History
Comment by
SPCEO1
on Nov 16, 2024 8:03pm
RE:SPCEO, are you still around ?
Yes, still check here every now and again. Still own our position. BTW, so do all the other large shareholders according to their updated SEC filings through 9/30/24. Clearly, there is an issue with
...more
(15)
•••
JayjayUSA12007
X
View Profile
View Bullboard History
Post by
JayjayUSA12007
on Nov 16, 2024 7:00pm
SPCEO, are you still around ?
Just wonder...
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 15, 2024 11:15am
RE:RE:Astra Zeneca - interest in tesamorelin?
The World is changing so must Thera. Make Thera great again.. lol.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Nov 14, 2024 11:52am
RE:Astra Zeneca - interest in tesamorelin?
Almost 2 years has passed since the truly fatidic event of The Pause. This is the only quick way to get our capital back in my book before my time on Earth is over.. lol.
(22)
•••
Joemare
X
View Profile
View Bullboard History
Post by
Joemare
on Nov 14, 2024 9:11am
Astra Zeneca - interest in tesamorelin?
AZ is pushing hard in the obesity market - what are the chances our TH super executives have had talks with them? Are they too busy re-organizing their sales force? Or busy posting on Linkedin
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden